PECIMONOVA, Martina, Emil POLAK, Frantisek CSICSAY, Kamila RÉBLOVÁ, Maja STOJILJKOVIC, Zdenko LEVARSKI, Ludovit SKULTETY, Ludevit KADASI and Andrea SOLTYSOVA. Functional and structural characterisation of 5 missense mutations of the phenylalanine hydroxylase. General physiology and biophysics. BRATISLAVA: General Physiol and Biophysic, 2017, vol. 36, No 4, p. 361-371. ISSN 0231-5882. Available from: https://dx.doi.org/10.4149/gpb_2017003.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Functional and structural characterisation of 5 missense mutations of the phenylalanine hydroxylase
Authors PECIMONOVA, Martina (703 Slovakia), Emil POLAK (703 Slovakia), Frantisek CSICSAY (703 Slovakia), Kamila RÉBLOVÁ (203 Czech Republic, guarantor, belonging to the institution), Maja STOJILJKOVIC (688 Serbia), Zdenko LEVARSKI (703 Slovakia), Ludovit SKULTETY (703 Slovakia), Ludevit KADASI (703 Slovakia) and Andrea SOLTYSOVA (703 Slovakia).
Edition General physiology and biophysics, BRATISLAVA, General Physiol and Biophysic, 2017, 0231-5882.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10600 1.6 Biological sciences
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.479
RIV identification code RIV/00216224:14740/17:00098089
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.4149/gpb_2017003
UT WoS 000412155000001
Keywords in English PAH mutations; Phenylketonuria; Specific activity; Chaperons; Functional study
Tags rivok
Changed by Changed by: Mgr. Eva Špillingová, učo 110713. Changed: 30/10/2017 15:45.
Abstract
Phenylketonuria (PKU) and hyperphenylalaninemia (HPA) are a group of genetic disorders predominantly caused by mutations in the phenylalanine hydroxylase (PAH) gene. To date, more than 950 variants have been identified, however the pathogenic mechanism of many variants remains unknown. In this study, in silico prediction and in vitro prokaryotic and eukaryotic expression systems were used to functionally characterise five PAH missense variants (p.F233I, p.R270I, p.F331S, p.S350Y, and p.L358F) previously identified in Slovak and Czech patients. p.F233I, p.R270I, and p.S350Y were classified as deleterious mutations since they showed no specific activity in functional assay and no response to chaperone co-expression. Protein levels of these PAH variants were very low when expressed in HepG2 cells, and only p.S350Y responded to BH4 precursor overload by significant increase in PAH monomer, probably due to reduced rate of protein degradation as the result of proper protein folding. Variants p.F331S and p.L358F exerted residual enzymatic activity in vitro. While the first can be classified as probably pathogenic due to its very low protein levels in HepG2 cells, the latter is considered to be mild mutation with protein levels of approximately 17.85% compared to wt PAH. Our findings contribute to better understanding of structure and function of PAH mutated enzymes and optimal treatment of PKU patients carrying these mutations using BH4 supplementation.
Links
LM2015085, research and development projectName: CERIT Scientific Cloud (Acronym: CERIT-SC)
Investor: Ministry of Education, Youth and Sports of the CR, CERIT Scientific Cloud
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 22/8/2024 12:38